102
is not part of the ACR core set of RA outcomes, outcome measures in rheumatology
(OMERACT), in 2006, endorsed the inclusion of fatigue in their core set [ 6 ]. Later
on and in concordance with the OMERACT recommendation, both the European
league against rheumatism (EULAR) and ACR recommended that fatigue should be
reported within the domain of disease activity in every randomized clinical trial [ 7 ].
Fig. 4.1 Transformation of rheumatoid arth ritis patients’ management: new model of integrated care
Fig. 4.2 Redefi ning health outcomes: management outcomes of rheumatoid arthritis
Y. El Miedany